This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. interactions that depend on animal and parasite species, (ii) their feasibility under field 28 conditions, (iii) appropriateness of study design, and (iv) the low analytic sensitivity of the 29 recommended faecal egg count (FEC) method. Therefore, the objective of the present study 30 was to empirically assess the impact of the level of excretion and aggregation of FEC, sample 31 size and detection limit of the FEC method on the sensitivity and specificity of the FECRT to 32 detect reduced efficacy (<90% or <95%) and to develop recommendations for surveys on 33 anthelmintic resistance. A simulation study was performed in which the FECRT (based on the 34 arithmetic mean of grouped FEC of the same animals before and after drug administration) 35 was conducted under varying conditions of mean FEC, aggregation of FEC (inversely 36 correlated with k), sample size, detection limit and "true" drug efficacies. Classification trees 37 were built to explore the impact of the above factors on the sensitivity and specificity of 38 detecting a truly reduced efficacy. For a reduced-efficacy threshold of 90%, most 39 combinations resulted in a reliable detection of reduced and normal efficacy. For the reduced-40 efficacy threshold of 95% however, unreliable FECRT results were found when sample sizes 41 <15 were combined with highly aggregated FEC (k = 0.25) and detection limits ≥5 EPG or 42 when combined with detection limits ≥15 EPG. Overall, an increase in sample size and mean 43 preDA FEC, and a decrease in detection limit improved the diagnostic accuracy. FECRT 44 remained inconclusive under any evaluated condition for drug efficacies ranging from 87.5% 45 to 92.5% for a reduced-efficacy-threshold of 90% and from 92.5% to 97.5% for a threshold of 46
The faecal egg count reduction test (FECRT) is the method of choice to monitor 23 anthelmintic efficacy against gastro-intestinal nematodes in livestock. Guidelines on how to 24 conduct a FECRT are made available by the World Association for the Advancement of 25 Veterinary Parasitology (WAAVP). Since the publication of these guidelines in the early 26 1990s, some limitations have been noted, including (i) the ignorance of host-parasite 27 interactions that depend on animal and parasite species, (ii) their feasibility under field 28 conditions, (iii) appropriateness of study design, and (iv) the low analytic sensitivity of the 29 recommended faecal egg count (FEC) method. Therefore, the objective of the present study 30 was to empirically assess the impact of the level of excretion and aggregation of FEC, sample 31 size and detection limit of the FEC method on the sensitivity and specificity of the FECRT to 32 detect reduced efficacy (<90% or <95%) and to develop recommendations for surveys on 33 anthelmintic resistance. A simulation study was performed in which the FECRT (based on the 34 arithmetic mean of grouped FEC of the same animals before and after drug administration) 35 was conducted under varying conditions of mean FEC, aggregation of FEC (inversely 36 correlated with k), sample size, detection limit and "true" drug efficacies. Classification trees 37 were built to explore the impact of the above factors on the sensitivity and specificity of 38 detecting a truly reduced efficacy. For a reduced-efficacy threshold of 90%, most 39 combinations resulted in a reliable detection of reduced and normal efficacy. For the reduced-40 efficacy threshold of 95% however, unreliable FECRT results were found when sample sizes 41 <15 were combined with highly aggregated FEC (k = 0.25) and detection limits ≥5 EPG or 42 when combined with detection limits ≥15 EPG. Overall, an increase in sample size and mean 43 preDA FEC, and a decrease in detection limit improved the diagnostic accuracy. FECRT 44 remained inconclusive under any evaluated condition for drug efficacies ranging from 87.5% 45 to 92.5% for a reduced-efficacy-threshold of 90% and from 92.5% to 97.5% for a threshold ofM a n u s c r i p t M a n u s c r i p t
Introduction 53
The periodic administration of anthelmintics is currently the most widely used method to 54 control gastrointestinal nematode infections in animals. Rather than aiming to achieve 55 elimination, these control programmes focus on reducing infection intensity and transmission 56 to prevent production losses (Shaw et The objective of the present study was to empirically assess the impact of sample size, 85 detection limit of the FEC method, and level of excretion and aggregation of FEC on the 86 interpretation of the FECRT in the absence of a control group. To this end, data were 87 generated using a statistical simulation and subsequently analysed using tree based-models. 88
From the results, we provide recommendations for future study designs to monitor drug 89 efficacy against gastrointestinal nematodes of veterinary importance. 90 91
Methods 92
The study consisted of two consecutive methodological procedures. First, data were 93 generated using a simulation in which the "true" drug efficacy (TDE) was evaluated by the 94 FECRT under varying conditions of level of excretion and aggregation of FEC across the host 95 population, sample size and detection limit of the FEC methods. Subsequently, the obtained 96 data were analyzed using tree-based models, to determine their impact on the interpretation of 97 FECRT and to assess critical values in terms of specificity to detect normal efficacy and 98 sensitivity to detect reduced efficacy. 99 observed, however, will be different from the "true" preDA FEC due to the variation (i.e. 113 stochasticity) introduced by sampling eggs associated with the FEC method. This component 114 of variation was simulated using the Poisson distribution defined by the expected number of 115 eggs counted (="true" preDA FEC/detection limit). In order to simulate a TDE, the "true" 116 preDA FECs of these animals were multiplied by 1-TDE. The observed FEC after the 117 administration of the drug (postDA FEC) was generated as described above for the preDA 118 FEC. Subsequently, the FECRT was calculated as described in the formula below 119 (Kochapakdee et al., 1995), and is based on the arithmetic mean of pre-and postDA FEC of 120 the same animals. Finally, the entire process was iterated 500 times, to obtain 500 estimates of 121 FECRT given a pre-defined parasite population, sample size, detection limit and TDE. 122 x (sample size) x 8 (detection limit) x 12 (TDE)) that were each iterated 500 times. 137 138 2.2. Analysis of data using tree-based models 139
The impact of the various factors on the sensitivity and specificity of the FECRT was 140 evaluated. Every TDE that was less than 90% or 95% was considered as a truly reduced 141 efficacy and as truly efficacious if different. 142
A combination of evaluated factors (500 iterations) was considered to be "sensitive" 143 when a FECRT could be calculated (observed mean preDA FEC >0) and a truly reduced 144 efficacy (TDE <90% or <95%) was correctly detected in at least 95% of the iterations or 145 "insensitive" (i.e. false negative) otherwise. A combination of evaluated factors was 146 considered to be "specific" when a FECRT could be calculated (observed mean preDA FEC 147 >0) and TDE ≥90 or ≥95% was correctly detected in at least 95% of the iterations or 148 "aspecific" (false positive) otherwise. The different combinations of sample size, detection limit, mean preDA FEC and k, and 160 their respective TDE limits for which the FECRT cannot reliably provide a correct diagnosis 161 (sensitivity and specificity <85%) are summarized in Figure 1 . 162
For small sample sizes (6 and 10 animals), detection limit was the most important factor: 163 the reliability of diagnosing reduced and normal efficacy increased when the detection limit 164 decreased. With a detection limit ≥15 EPG reduced and normal efficacy could only reliably be 165 detected when the TDE ≤60% and ≥95%, respectively, whereas a detection limit of 1 and 2 166 EPG allowed to accurately detect reduced and normal efficacy up to a TDE of ≤87.5% and 167
≥95.0%, respectively. 168
For moderate (15 and 25 animals) sample sizes, FECRT results were also affected by 169 mean preDA FEC: FECRT results were less discriminatory when mean preDA FEC 170 decreased. However, the impact of mean preDA FEC on the detection of reduced and normal 171 efficacy decreased when detection limit decreased. For detection limits ≥15 EPG, the TDE 172 limits where ≤60% and ≥95% when mean preDA FEC were low (50 and 100 EPG), whereas 173 detection of normal and reduced efficacy became more reliable when mean preDA FEC wereA c c e p t e d M a n u s c r i p t 9 accurately detect reduced and normal drug efficacy were ≤87.5% and ≥95.0%, regardless of 176 the mean preDA FEC. 177
For large sample sizes (≥ 50 animals), the FECRT was able to detect reduced and normal 178 efficacy when TDE were ≤87.5% and ≥92.5%, except for combinations where detection limits 179 ≥10 EPG were combined with a mean preDA FEC of 50 and 100 EPG, for these combinations 180 the TDE limits were ≤82.5% and ≥92.5%. 181
For the 90% threshold aggregation of the FEC (k) had no effect on specificity or 182 sensitivity. 183 <Figure 1 near here> 184 185
Detection of a normal or reduced efficacy for a threshold of 95% 186
In analogy with a threshold of 90%, the different combinations of sample size, detection 187 limit, mean preDA FEC and k, and their respective TDE limits are summarized in Figure 2 . In 188 comparison with a threshold of 90%, four important differences can be noted. highlight that their will always be an interval of TDE for which the FECRT remains 214 inconclusive, even in optimal conditions of sample size, detection limit, mean preDA FEC 215 and aggregation (cfr. Figure 1 and 2) . These intervals range from 87.5% to 92.5% and from 216 92.5% to 97.5% for a 90% and 95% threshold, respectively. Finally, the results indicate that 217 recommendations on the sample size can be less stringent in cases where FEC methods that 218 are more sensitive than McMaster are applied. We, therefore, believe that Figures 1 and 2 can 219 provide researchers with the flexibility to adapt their study design according to a wide range 220 of field conditions. 221
A c c e p t e d M a n u s c r i p t 11 found sensitivity to be around 90-95%, that is, most resistant nematode isolates were correctly 225 diagnosed as resistant. The results of this study were consistent with their findings as the 226 range of true drug efficacies that provide doubtful results were generally greater below the 227 threshold than above it (cfr. Figure 1 and 2) . In practice other factors that may lead to a false 228 declaration of reduced efficacy, such as faulty equipment, incorrect dosage, missed animals, 229 sub-standard product, miss-labeled samples etc. were not considered in this exercise. In the 230 laboratory and on farm these are errors that can be difficult to eliminate completely and will 231 tend to reduce FECRT specificity. By comparison with preDA FEC, detection level and 232 sample size aggregation of FEC (k) played a minor role in FECRT precision when the 233 threshold was 95% and had no effect on precision when the threshold was 90%. This was 234 because the simulated study design 
